Surgical management of distant metastases.

作者: David W. Ollila , Abigail S. Caudle

DOI: 10.1016/J.SOC.2005.12.003

关键词:

摘要: Although the location of metastases is prognostic importance in stage IV melanoma, as seen revised AJCC staging classification system and other studies, certain guiding principles apply to patients who have any disease. Close follow-up patient has melanoma may identify surgically resectable metastatic disease, although this method controversial. Components monitoring include careful questioning determine symptoms, such cough, abdominal pain, or headaches; physical examination for evidence skin, soft tissue, lymph node metastases; screening tools, radiographs laboratory tests. Identifying disease at earliest possible crucial surgical resection be an option. Patients should also thoughtfully evaluated possibility a complete re-section. Complete metastectomy, regardless anatomic site, confers survival advantages not with treatment modalities. This aggressive approach tempered knowledge that incomplete resections put increased risk without proven benefit, reserved only palliation symptoms. Systemic adjuvant therapies are evolving, but do yet confer advantage resection. Until novel drug show efficacy significantly prolong consideration given metastectomy if technically feasible.

参考文章(84)
John D. Johnson, Byron Young, Demographics of brain metastasis. Neurosurgery Clinics of North America. ,vol. 7, pp. 337- 344 ,(1996) , 10.1016/S1042-3680(18)30365-6
Morton Dl, Barth A, Wanek La, Prognostic factors in 1,521 melanoma patients with distant metastases. Journal of The American College of Surgeons. ,vol. 181, pp. 193- 201 ,(1995)
Jönsson Pe, Ingvar C, Oredsson S, Strömblad Lg, Palliative surgery for brain metastases of malignant melanoma. Ejso. ,vol. 16, pp. 451- 456 ,(1990)
David H. Harpole, Cheryl M. Johnson, Walter G. Wolfe, Stephen L. George, Hilliard F. Seigler, ANALYSIS OF 945 CASES OF PULMONARY METASTATIC MELANOMA The Journal of Thoracic and Cardiovascular Surgery. ,vol. 103, pp. 743- 750 ,(1992) , 10.1016/S0022-5223(19)34957-8
Andrew E. Radbill, John F. Fiveash, Elizabeth T. Falkenberg, Barton L. Guthrie, Paul E. Young, Sreelatha Meleth, James M. Markert, Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer. ,vol. 101, pp. 825- 833 ,(2004) , 10.1002/CNCR.20447
G M Hutchins, G W Moore, S M de la Monte, Patterned distribution of metastases from malignant melanoma in humans. Cancer Research. ,vol. 43, pp. 3427- 3433 ,(1983)
D Khayat, C Borel, J M Tourani, A Benhammouda, E Antoine, O Rixe, E Vuillemin, P A Bazex, L Thill, R Franks, Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma. Journal of Clinical Oncology. ,vol. 11, pp. 2173- 2180 ,(1993) , 10.1200/JCO.1993.11.11.2173
U Keilholz, C Conradt, S S Legha, D Khayat, C Scheibenbogen, N Thatcher, S H Goey, M Gore, T Dorval, B Hancock, C J Punt, R Dummer, M F Avril, E B Bröcker, A Benhammouda, A M Eggermont, M Pritsch, Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. Journal of Clinical Oncology. ,vol. 16, pp. 2921- 2929 ,(1998) , 10.1200/JCO.1998.16.9.2921
Jon M. Richards, Danielle Gale, Nilesh Mehta, Timothy Lestingi, Combination of Chemotherapy With Interleukin-2 and Interferon Alfa for the Treatment of Metastatic Melanoma Journal of Clinical Oncology. ,vol. 17, pp. 651- 651 ,(1999) , 10.1200/JCO.1999.17.2.651
M.R. Middleton, J.J. Grob, N. Aaronson, G. Fierlbeck, W. Tilgen, S. Seiter, M. Gore, S. Aamdal, J. Cebon, A. Coates, B. Dreno, M. Henz, D. Schadendorf, A. Kapp, J. Weiss, U. Fraass, P. Statkevich, M. Muller, N. Thatcher, Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma Journal of Clinical Oncology. ,vol. 18, pp. 158- 166 ,(2000) , 10.1200/JCO.2000.18.1.158